Breaking News
Inside the Fight ff MI6 and CIA Proxies Over Who Is To Lead Ukraine
The Real Elites vs. The Ruling Elites
The State Spins a New Idea for Recruiting in an Age of War
Woke Nike Booted from S&P 100 as Stock Crashes on Dismal Sales
Top Tech News
Floating data center would provide water and electricity to 32,000 homes
OpenAI Cuts Off Elon's Cursor, Humanity's First Star Probe, and Trump's Nuclear Mars Shi
Eating pollution? Plastic-to-cookie technology raises safety, environmental concerns
Ford's $30,000 Fathom EV Truck Appears More Conventional Than Expected
Berlin-based artist Simon Weckert explored that idea with Digital Camouflage...
Tether expands tokenization business into Saudi Arabia, starting with real estate
Ukraine is facing a new problem in its war with Russia:
It charges more than it discharges while driving
Dataminr AI tech to go live on NATO Maven system: CEO 
The Most Dangerous Interview Ever Recorded? PART 2 
'TUMOUR KILLER' Cancer patients 'CURED' after doctors turbocharge their blood's
Two adults with leukaemia have been in remission since 2010 after Car-T therapy.
It involves removing blood and genetically modifying its white cells so they target cancer.
The resulting Car-T cells are re-injected in a type of immunotherapy which uses the body's immune system to attack tumours.
Levels of the cells in the two cured patients remain high.
Dr Carl June, of the University of Pennsylvania, US, said: "Based on these results, we can conclude that Car-T cells can cure leukaemia.
"These cells continued to demonstrate tumour-killing characteristics."
Patient Doug Olsen said medics could not find any cancer after a few weeks. He said: "I knew the doctors weren't sure but I was pretty convinced that I was done with cancer."
The NHS offers Car-T to some children with leukaemia and adults with lymphoma.
It warns the therapy can make the immune system over-react or trigger side effects such as fever, vomiting or breathing difficulties.